Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $3.48 billion. The enterprise value is $3.24 billion.
| Market Cap | 3.48B |
| Enterprise Value | 3.24B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 19.60 million shares outstanding. The number of shares has increased by 5.60% in one year.
| Current Share Class | 19.60M |
| Shares Outstanding | 19.60M |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | +3.83% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 100.73% |
| Float | 19.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 47.59 |
| PS Ratio | 18.57 |
| Forward PS | 11.20 |
| PB Ratio | 4.20 |
| P/TBV Ratio | 7.30 |
| P/FCF Ratio | 64.96 |
| P/OCF Ratio | 62.92 |
| PEG Ratio | 3.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 253.84, with an EV/FCF ratio of 60.49.
| EV / Earnings | -42.76 |
| EV / Sales | 17.29 |
| EV / EBITDA | 253.84 |
| EV / EBIT | n/a |
| EV / FCF | 60.49 |
Financial Position
The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.45 |
| Quick Ratio | 4.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.11 |
| Interest Coverage | -3.92 |
Financial Efficiency
Return on equity (ROE) is -9.46% and return on invested capital (ROIC) is -1.11%.
| Return on Equity (ROE) | -9.46% |
| Return on Assets (ROA) | -0.98% |
| Return on Invested Capital (ROIC) | -1.11% |
| Return on Capital Employed (ROCE) | -1.62% |
| Revenue Per Employee | $2.76M |
| Profits Per Employee | -$1.12M |
| Employee Count | 68 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 4.67 |
Taxes
| Income Tax | -8.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.53% in the last 52 weeks. The beta is 0.83, so LGND's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +33.53% |
| 50-Day Moving Average | 108.07 |
| 200-Day Moving Average | 110.47 |
| Relative Strength Index (RSI) | 55.94 |
| Average Volume (20 Days) | 140,889 |
Short Selling Information
The latest short interest is 1.15 million, so 5.98% of the outstanding shares have been sold short.
| Short Interest | 1.15M |
| Short Previous Month | 1.23M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 5.02 |
Income Statement
In the last 12 months, LGND had revenue of $187.58 million and -$75.86 million in losses. Loss per share was -$4.00.
| Revenue | 187.58M |
| Gross Profit | 107.79M |
| Operating Income | -14.30M |
| Pretax Income | -84.50M |
| Net Income | -75.86M |
| EBITDA | 19.73M |
| EBIT | -14.30M |
| Loss Per Share | -$4.00 |
Balance Sheet
The company has $245.02 million in cash and $5.74 million in debt, giving a net cash position of $239.28 million or $12.21 per share.
| Cash & Cash Equivalents | 245.02M |
| Total Debt | 5.74M |
| Net Cash | 239.28M |
| Net Cash Per Share | $12.21 |
| Equity (Book Value) | 828.53M |
| Book Value Per Share | 42.68 |
| Working Capital | 288.21M |
Cash Flow
In the last 12 months, operating cash flow was $55.36 million and capital expenditures -$1.74 million, giving a free cash flow of $53.62 million.
| Operating Cash Flow | 55.36M |
| Capital Expenditures | -1.74M |
| Free Cash Flow | 53.62M |
| FCF Per Share | $2.74 |
Margins
Gross margin is 57.46%, with operating and profit margins of -7.62% and -40.44%.
| Gross Margin | 57.46% |
| Operating Margin | -7.62% |
| Pretax Margin | -45.04% |
| Profit Margin | -40.44% |
| EBITDA Margin | 10.52% |
| EBIT Margin | -7.62% |
| FCF Margin | 28.58% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -2.18% |
| FCF Yield | 1.54% |
Analyst Forecast
The average price target for LGND is $144.71, which is 27.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.71 |
| Price Target Difference | 27.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 17.32% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
LGND has an Altman Z-Score of 11.36 and a Piotroski F-Score of 3.
| Altman Z-Score | 11.36 |
| Piotroski F-Score | 3 |